Catalyst Wire Dossier Catalyst Wire Dossier

Aczone 7.5%

dapsone · Sun Pharmaceutical Industries, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Aczone 7.5%, covering 2017-05-04 to 2020-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 3]

See pricing